Home News EdisonTV – Executive Interview with…

In this interview, CEO Dr Manfred Rüdiger explains the core technology of Kiadis’s business and the immunotherapies it is developing, optimising and harnessing to create therapeutic products. He discusses problems associated with stem cell transplantation in blood disorders and how Kiadis Pharma is working to address them as well as the patient population and market opportunity for its products. He also provides an overview of the competitive advantages of Kiadis Pharma products with respect to the current standard of care and other competitors. Finally, he outlines the regulatory strategy and provides timelines for the next value inflection points.

Click here to see the full interview.